Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 3 (ZBTB3) is a transcription factor belonging to the zinc finger and BTB/POZ domain-containing protein family. It is predicted to regulate transcription by RNA polymerase II, functioning predominantly as a DNA-binding factor in the nucleus. ZBTB3 acts as a critical regulator of cellular growth by modulating the reactive oxygen species (ROS) detoxification pathway, essential for cancer cell survival; suppression leads to increased ROS and apoptosis via caspase activation in cancer models. Additionally, ZBTB3 mediates chromatin looping, which can influence promoter selection (such as for immune-regulatory genes like IRF5), linking it to autoimmunity through effects on macrophage polarization. Its role in cancer biology and immune regulation highlights ZBTB3 as a potential therapeutic target, though direct pharmacological agents are not currently described.
Not directly described for drugs, but inhibition (e.g., by shRNA) of ZBTB3 results in increased ROS, decreased antioxidant gene expression, and apoptosis via activation of the caspase cascade. Potential future approaches may aim to inhibit ZBTB3 to selectively induce cancer cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 3 (ZBTB3).